Vered Rosenberger

Title: Vered Rosenberger: Innovator in Topical Montelukast Formulations

Introduction

Vered Rosenberger is a notable inventor based in Givatayim, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical formulations. With a total of 5 patents to his name, Rosenberger's work focuses on enhancing the delivery and efficacy of medications.

Latest Patents

Rosenberger's latest patents include innovative topical emulsion formulations containing Montelukast. One of his disclosures provides a topical emulsion comprising about 0.5% to about 10% Montelukast or its pharmaceutically acceptable salt, along with about 0.4% to about 4% carbomer. The formulation ensures that the Montelukast particles have a D90 of less than about 50 μm, with a pH range of about 3.0 to about 6.5. Additionally, he has developed a topical gel that includes about 0.5% to about 10% Montelukast, about 0.2% to about 8% cellulose polymer, and about 80% to about 95% amphiphilic compound, with less than 4% water content.

Career Highlights

Throughout his career, Vered Rosenberger has worked with Taro Pharmaceutical Industries Limited, where he has contributed to various pharmaceutical innovations. His expertise in formulation science has positioned him as a key player in the development of effective topical treatments.

Collaborations

Rosenberger has collaborated with notable professionals in the industry, including Avi Avramoff and Helena Shifrin. These collaborations have further enriched his work and contributed to the advancement of pharmaceutical formulations.

Conclusion

Vered Rosenberger's innovative work in topical Montelukast formulations showcases his dedication to improving pharmaceutical delivery systems. His contributions continue to impact the field positively, making him a significant figure in the realm of pharmaceutical inventions.